AnaptysBio, Inc. (ANAB) vs Nuvation Bio Inc. (NUVB)
- AnaptysBio, Inc. ANAB 45.61 −0.26%
- Nuvation Bio Inc. NUVB 3.92 +2.08%
AnaptysBio, Inc. and Nuvation Bio Inc. are both Biotechnology companies. AnaptysBio, Inc. and Nuvation Bio Inc. are of similar size ($1.4B and $1.4B). Nuvation Bio Inc. has negative trailing earnings, so its P/E is not meaningful; AnaptysBio, Inc. trades at 73.6×. Nuvation Bio Inc. grew revenue faster over the last twelve months: 654.2% against 95.2%. AnaptysBio, Inc. has the higher net margin (6.54% vs −67.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, AnaptysBio, Inc. leads on 12 and Nuvation Bio Inc. on 4.
Valuation
Profitability
| Metric | ANAB | NUVB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.79% | 70.18% |
| Operating margin | 36.14% | (61.17%) | 0.00% |
| Net margin | 6.54% | (67.38%) | 0.00% |
| Free cash flow margin | 0.00% | (53.62%) | 0.00% |
| Return on equity | (365.73%) | (49.09%) | (50.72%) |
| Return on assets | 4.76% | (19.70%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack